Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

wessling hungary kft. - ungaria - topiramatum - compr. film. - 25mg - antiepileptice alte antiepileptice

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

wessling hungary kft. - ungaria - topiramatum - compr. film. - 50mg - antiepileptice alte antiepileptice

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

upsa sas - franta - paracetamolum - sol. orala - 30 mg/ml - alte analgezice si antipiretice anilide (inclusiv combinatii)

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

abbott laboratories gmbh - germania - pancreatinum - caps. gastrorez. - 420mg - enzime digestive preparate enzimatice

Европейски съюз - румънски - EMA (European Medicines Agency)

mylan ire healthcare limited - pretomanid - tuberculoză, rezistentă la diferite medicamente - antimicobacteriene - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). trebuie luate în considerare ghidurile oficiale referitoare la utilizarea adecvată a medicamentelor antibacteriene.

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

piramal critical care bv - olanda - sevofluranum - lichid pt. vapori de inhal. - anestezice generale derivati halogenati ai hidrocarburilor

Европейски съюз - румънски - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfom, mantle-cell - agenți antineoplazici - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Европейски съюз - румънски - EMA (European Medicines Agency)

nova laboratories ireland limited - azathioprine - respingerea grefei - imunosupresoare - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

wrafton laboratories ltd. - marea britanie - combinatii - sirop - alte analgezice si antipiretice anilide (inclusiv combinatii)

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

esteve pharmaceuticals, s.a. - spania - omeprazolum - caps. gastrorez. - 10mg - med. pt. trat. ulcerului gastro-duodenal si bolii-reflux g.e inhibitori ai pompei de protoni